“Consuming three cups of coffee or 200-300 mg caffeine, per day might help to reduce the risk of developing cardio-metabolic multi-morbidity in individuals without any cardio-metabolic disease.”
-Chaofu Ke, MD, PhD, School of Public Health, Suzhou Medical College, Soochow University, China
Researchers conducting this study have come to the conclusion that on regular coffee/caffeine intake at a moderate level was associated with a lower risk of CM. CM is cardio-metabolic disease that refers to the co-existence of at least two cardio-metabolic diseases. This is an increasing public health concern among the elderly all around the world. The coffee and caffeine could provide a protective role in almost all the phases of the CM development. This includes diseases such as type 2 diabetes, coronary heart disease and stroke. The new research was published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. In this research, a comparison between non-consumers/consumers of less than 100 mg caffeine per day and consumers of moderate amount of caffeine which is 200-300 mg per day had a 48.1% reduction of risks for an early onset of CM. Ke and his colleagues obtained the data findings from the UK Biobank. This study did not include individuals with an ambiguous information on their caffeine intake. Participants’ CM outcomes were identified from self-reported medical conditions, primary care data, linked in-patient hospital data and death registry records that were linked to the UK Biobank.
Ke and his colleagues based their findings on data from the UK Biobank, a large and detailed longitudinal dietary study with over 500,000 participants aged 37-73 years. The study excluded individuals who had ambiguous information on caffeine intake. The resulting pool of participants included a total of 172,315 individuals who were free of any cardio-metabolic diseases at the baseline for the analyses of the caffeine, and a corresponding 188,091 individuals for the analyses of the coffee and the tea consumption.
The participants’ cardio-metabolic diseases outcomes were identified from self-reported medical conditions, primary care data, linked in-patient hospital data and death registry records linked to the UK Biobank. Numerous studies have highlighted the benefits and positive effects of tea, coffee and caffeine consumption on the morbidity rates of a single cardio-metabolic disease. But, this was not done for CM until very recently.
